Connect
MJA
MJA

Commercialism, choice and consumer protection: regulation of complementary medicines in Australia

C Scott Masters
Med J Aust 2008; 189 (1): 50-53.
Published online: 7 July 2008

To the Editor: Harvey et al1 have a right to be concerned about the parlous state of regulation in the billion-dollar complementary medicine (CM) industry. They are not alone, with various leaders from CM doctor groups and other leaders also expressing concern.2,3

  • C Scott Masters

  • Musculoskeletal Medicine, Caloundra Sports Medicine Centre, Caloundra, QLD.

Correspondence: k.harvey@medreach.com.au

Competing interests:

I have been paid speaker fees and travel allowances to speak on musculoskeletal medicine topics by Boehringer, Pfizer, Mundipharma and Merck Sharpe & Dohme.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.